01.04.2011 | Research Articles
Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)
Erschienen in: Clinical and Translational Oncology | Ausgabe 4/2011
Einloggen, um Zugang zu erhalten